超声与病理不一致的甲状腺结节在核心针活检中的恶性风险与管理策略
本研究回顾性分析了2008年7月至2011年11月间166个超声可疑但核心针活检(CNB)良性的甲状腺结节。其中7个(4.2%)确诊为恶性,不同超声风险系统评估的恶性风险范围为3.6%至5.5%。作者认为,对于具有两个以上可疑超声特征的特定结节,可能需要重复活检。
要点
- 超声可疑但CNB良性的甲状腺结节恶性风险为3.6%至5.5%(因超声风险系统而异)。
- 166个不一致结节中7个(4.2%)确诊恶性。
- 可疑超声特征的数量与恶性相关(p=0.002)。
核心结论
- 超声与CNB结果不一致的甲状腺结节恶性风险为3.6%至5.5%,取决于超声风险系统。
- 对于具有两个以上可疑超声特征的特定甲状腺结节,可能需要重复活检。
研究设计与样本
- 回顾性研究,纳入2008年7月至2011年11月间1309例患者的1313个甲状腺结节,均接受超声引导下CNB。
- 其中166个超声可疑但CNB良性的结节被回顾性分析。
- 良性诊断依据手术、FNA和/或至少重复两次的CNB或CNB联合随访中病灶大小稳定。
主要发现
- 166个超声-病理不一致结节中,7个(4.2%)确诊为恶性。
- 五种超声风险系统评估的恶性风险范围为3.6%至5.5%。
- 可疑超声特征中,仅可疑特征的数量与恶性相关(p=0.002)。
- 良性CNB标本的组织学分析显示纤维化(77.6%)、甲状腺炎(28.7%)、钙化(10.6%)和含铁血黄素沉积(6.4%)。
- 良性与恶性结节患者的临床和人口学特征无显著差异。
临床怎么用
- 对于超声可疑但CNB良性的甲状腺结节,应根据所用超声风险系统评估恶性风险(3.6%至5.5%)。
- 作者认为,对于具有两个以上可疑超声特征的特定结节,可能需要重复活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The reported malignancy rates of thyroid nodules that appear suspicious on ultrasound (US) but yield benign fine-needle aspiration (FNA) cytology results range from 13.6% to 56.6%. However, the malignancy risk of nodules that are discordant on US and core-needle biopsy (CNB) pathological findings has not been evaluated. This study evaluated the malignancy risk associated with thyroid nodules that are suspicious on US but yield benign CNB results. METHODS: Between July 2008 and November 2011, 1309 patients with 1313 thyroid nodules underwent US-guided CNB. Among these, 166 thyroid nodules that were suspicious on US but yielded benign CNB results were retrospectively reviewed. Benign nodules were diagnosed by surgery, FNA, and/or CNB that was repeated at least twice or CNB and lesion size stability on follow-up. The malignancy risk of US-pathology discordant nodules was calculated according to recommendations by Moon et al., and a further evaluation was conducted using four different US risk systems. Factors that differentiated benign from malignant nodules were assessed using the chi-square test or Fisher's exact test. Moreover, the histological findings of US-pathology discordant nodules were analyzed. RESULTS: Patients with benign and malignant nodules did not differ significantly regarding clinical and demographic characteristics. Of the 166 US-pathology discordant nodules, seven (4.2%) were confirmed malignant. The malignancy risks associated with the five US risk systems ranged from 3.6% to 5.5%. Regarding suspicious US features, only the number of suspicious features was associated with malignancy (p = 0.002). Histological analysis of benign CNB specimens with suspicious US features revealed fibrosis (77.6%), thyroiditis (28.7%), calcifications (10.6%), and hemosiderin deposition (6.4%). CONCLUSIONS: The malignancy risk among thyroid nodules with discordant US and CNB results ranged from 3.6% to 5.5%, depending on US risk systems. However, repeated biopsy may be necessary for selected thyroid nodules with more than two suspicious US features.
引用
- Chung SR, Baek JH, Park HS, et al. Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy. Thyroid. 2017. PMID: 28326900. doi:10.1089/thy.2016.0462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。